Literature Review of Traditional Chinese Medicine Herbs–Induced Liver Injury From an Oncological Perspective With RUCAM

• Main Authors: Hei Ching Chow, Tsz Him So BChinMed, MBBS, FRCR, Horace Cheuk Wai Choi PhD, Ka On Lam MBBS, FRCR
• Format: Article
• Language: English
• Published: SAGE Publishing 2019-08-01
• Series: Integrative Cancer Therapies
• Online Access: https://doi.org/10.1177/1534735419869479

Traditional Chinese medicine (TCM) herbs are commonly regarded to be safe with minimal toxicities in Chinese communities. Cancer patients who are receiving Western oncology therapy often concurrently take TCM herbs for anticancer and symptom relief purposes. We performed a literature review for current evidence on TCM herb–induced liver injury from an oncological perspective. A literature search on PubMed was performed to identify publications regarding TCM herbs and concoctions with hepatoprotective or hepatotoxic properties. Lists of commonly used herbs and their causality levels were compiled. In view of the wide range of evidence available, cases assessed by the well-established RUCAM (Roussel Uclaf Causality Assessment Method) algorithm were categorized as the highest level of evidence. More than one case of TCM herb–induced liver injury was confirmed by RUCAM in the following herbs and concoctions: Lu Cha ( Camellia sinensis ), Bai Xian Pi ( Dictamnus dasycarpus ), Tu San Qi ( Gynura segetum ), Jin Bu Huan ( Lycopodium serratum ), He Shou Wu ( Polygoni multiflora ), Ge Gen ( Pueraria lobata ), Dan Lu Tong Du tablet, Shou Wu Pian, Xiao Chai Hu Tang, Xiao Yin pill, and Yang Xue Sheng Fa capsule. Finally, TCM with anticancer or symptom relief uses were discussed in detail with regard to their hepatotoxic or hepatoprotective properties.